These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23121838)

  • 1. Silymarin inhibits cell cycle progression and mTOR activity in activated human T cells: therapeutic implications for autoimmune diseases.
    Gharagozloo M; Javid EN; Rezaei A; Mousavizadeh K
    Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):251-6. PubMed ID: 23121838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive effect of silymarin on mitogen-activated protein kinase signalling pathway: the impact on T cell proliferation and cytokine production.
    Gharagozloo M; Jafari S; Esmaeil N; Javid EN; Bagherpour B; Rezaei A
    Basic Clin Pharmacol Toxicol; 2013 Sep; 113(3):209-14. PubMed ID: 23701595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive effects of DTCM-G, a novel inhibitor of the mTOR downstream signaling pathway.
    Shibasaki S; Yamashita K; Goto R; Wakayama K; Tsunetoshi Y; Zaitsu M; Igarashi R; Haga S; Ozaki M; Umezawa K; Todo S
    Transplantation; 2013 Feb; 95(4):542-50. PubMed ID: 23269193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,25-Dihydroxyvitamin D3-3-bromoacetate, a novel vitamin D analog induces immunosuppression through PI3K/Akt/mTOR signaling cascade.
    Datta-Mitra A; Mitra A; Ray R; Raychaudhuri SP; Kundu-Raychaudhuri S
    Int Immunopharmacol; 2013 Nov; 17(3):744-51. PubMed ID: 24036370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response.
    Shepherd C; Banerjee L; Cheung CW; Mansour MR; Jenkinson S; Gale RE; Khwaja A
    Leukemia; 2013 Mar; 27(3):650-60. PubMed ID: 23038273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells.
    Zi X; Grasso AW; Kung HJ; Agarwal R
    Cancer Res; 1998 May; 58(9):1920-9. PubMed ID: 9581834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
    deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
    Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanisms.
    Kristof AS; Pacheco-Rodriguez G; Schremmer B; Moss J
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1134-43. PubMed ID: 15923340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric cancer growth control by BEZ235 in vivo does not correlate with PI3K/mTOR target inhibition but with [18F]FLT uptake.
    Fuereder T; Wanek T; Pflegerl P; Jaeger-Lansky A; Hoeflmayer D; Strommer S; Kuntner C; Wrba F; Werzowa J; Hejna M; Müller M; Langer O; Wacheck V
    Clin Cancer Res; 2011 Aug; 17(16):5322-32. PubMed ID: 21712451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embelin inhibits growth and induces apoptosis through the suppression of Akt/mTOR/S6K1 signaling cascades.
    Kim SW; Kim SM; Bae H; Nam D; Lee JH; Lee SG; Shim BS; Kim SH; Ahn KS; Choi SH; Sethi G; Ahn KS
    Prostate; 2013 Feb; 73(3):296-305. PubMed ID: 22887478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of silymarin on the proliferation and glutathione levels of peripheral blood mononuclear cells from beta-thalassemia major patients.
    Alidoost F; Gharagozloo M; Bagherpour B; Jafarian A; Sajjadi SE; Hourfar H; Moayedi B
    Int Immunopharmacol; 2006 Aug; 6(8):1305-10. PubMed ID: 16782543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
    Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
    Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
    García-Maceira P; Mateo J
    Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade.
    Mitra A; Raychaudhuri SK; Raychaudhuri SP
    Cytokine; 2012 Oct; 60(1):38-42. PubMed ID: 22840496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Apoptosis and Proliferation in T Cells by Immunosuppressive Silymarine.
    Almasi E; Gharagozloo M; Eskandari N; Almasi A; Sabzghabaee AM
    Iran J Allergy Asthma Immunol; 2017 Apr; 16(2):107-119. PubMed ID: 28601050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.
    Peponi E; Drakos E; Reyes G; Leventaki V; Rassidakis GZ; Medeiros LJ
    Am J Pathol; 2006 Dec; 169(6):2171-80. PubMed ID: 17148679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins.
    Zi X; Feyes DK; Agarwal R
    Clin Cancer Res; 1998 Apr; 4(4):1055-64. PubMed ID: 9563902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer.
    Hogan FS; Krishnegowda NK; Mikhailova M; Kahlenberg MS
    J Surg Res; 2007 Nov; 143(1):58-65. PubMed ID: 17950073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infection.
    Morishima C; Shuhart MC; Wang CC; Paschal DM; Apodaca MC; Liu Y; Sloan DD; Graf TN; Oberlies NH; Lee DY; Jerome KR; Polyak SJ
    Gastroenterology; 2010 Feb; 138(2):671-81, 681.e1-2. PubMed ID: 19782083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer.
    Baan B; Dihal AA; Hoff E; Bos CL; Voorneveld PW; Koelink PJ; Wildenberg ME; Muncan V; Heijmans J; Verspaget HW; Richel DJ; Hardwick JC; Hommes DW; Peppelenbosch MP; van den Brink GR
    Gut; 2012 Dec; 61(12):1708-15. PubMed ID: 22187071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.